Nath Bio-Genes (India) Limited
Incorporated in 1993, Nath Bio-Genes Ltdis in the business of Production, Processing,and Marketing of Hybrid and GM Seeds
What Nath files
- Others30
- Important11
- Board Meeting7
- Updates6
- Investor Meet3
- Dividend/Bonus2
Nath Bio-Genes delivered H1 FY'26 revenue of 319.9 Cr (+15.9% YoY) and PAT of 42.4 Cr (+15.3% YoY). Cotton (value +26.3%), Maize (volume +7.3%), and Vegetable seeds (value +25%) propelled growth. R&D and product innovation are strategic drivers, with the Uzbekistan JV progressing. Working capital increased to 413.47 Cr.
Nath Bio-Genes posted strong Q2 with revenue up 23.5% to ₹39.8 Cr and PAT up 45.4% to ₹4.2 Cr. H1 revenue grew 15.9% to ₹319.9 Cr and PAT by 15.3% to ₹42.4 Cr. Cotton sales rose, while Vegetable Seeds saw robust 24.4% growth. Uzbekistan JV also performed well.
Nath Bio-Genes (NATHBIOGEN) has scheduled an earnings conference call. Management will discuss financial results for the quarter and half-year. Dial-in details are available for investors.
Nath Bio-Genes has announced a board meeting on the unaudited financial results for Q1 FY26. The company reported 15% revenue growth to ₹2802 Mn, driven by strong volume and value growth in cotton (+16% volume, +21% value) and maize (+5% volume, +24% value). Paddy value rose 9% despite a volume...
Nath Bio-Genes reported a 14.5% YoY revenue increase to INR 49.4 Cr in Q4 and an 8.9% rise to INR 362.3 Cr for FY25. Gross profit improved by 7.1% YoY in Q4, reaching INR 33.8 Cr with a strong margin of 62.8%. However, Q4 EBITDA dropped 29.4% YoY to INR...